Currently out of the existing stock ratings of John Ransom, 275 are a BUY (93.54%), 19 are a HOLD (6.46%).

John Ransom

Work Performance Price Targets & Ratings Chart

Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 67.2% that have a potential upside of 33.44% achieved within 302 days.

John Ransom’s has documented 554 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services, Industrials sectors.

Most recent stock forecast was given on ACHC, Acadia Healthcare Company at 04-May-2026.

Wall Street Analyst John Ransom

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for RDNT (RADNET) at 11/13/2019. The price target of $18.5 was fulfilled within 8 days with a profit of $2.69 (17.01%) receiving and performance score of 21.27.

Average potential price target upside

of $89.26 (93.21%) on AME (AMETEK).
of $87.07 (36.21%) on HUM (HUMANA).
of $78.39 (27.02%) on UNH (UNITEDHEALTH GROUP).

ACHC Acadia Healthcare Company ADUS Addus HomeCare ALHC Alignment Healthcare LLC AMED Amedisys AVAH Aveanna Healthcare Holdings CI Cigna Corp CVET Covetrus CVS CVS Health Corp DVA DaVita HealthCare Partners EHC Encompass Health Corp HCA HCA Holdings HSKA Heska OSH Oak Street Health PHR Phreesia RDNT RadNet THC Tenet Healthcare UNH UnitedHealth Group AGTI Agiliti HCAT Health Catalyst AIRS Airsculpt Technologies PINC Premier SCI Service International CANO Cano Health ACCD Accolade CHNG Change Healthcare TRUP Trupanion GDRX Goodrx Holdings HUM Humana WBA Walgreens Boots Alliance AME Ametek GRDN Guardian Pharmacy Services OS OneStream, Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Brian Tanquilut (JEFFERIES)